bronchiestasis treatment centers

Lung Institute Treatment Centers for Natural Bronchiectasis Therapy

The Lung Institute’s locations throughout the United States are the only stem cell treatment centers in the world to focus solely on bronchiectasis and other chronic lung diseases. At the Lung Institute, we offer stem cell therapy as a natural treatment option for a number of restrictive and obstructive lung diseases. More than 80 percent of our patients report seeing improvement in not only their condition, but also their overall quality of life, following stem cell therapy.

When you visit one of our treatment centers seeking relief from symptoms associated with bronchiectasis, a dedicated Lung Institute doctor will work with you to determine the best form of therapy based on your specific condition. We offer two different forms of stem cell therapy: venous (derived from the patient’s blood) and bone marrow (derived from the patient’s bone marrow). Both of these procedures:

  • Are performed on an outpatient basis over a period of two days
  • Utilize autologous stem cells, or stem cells derived from the patient’s own body, so there is virtually no risk of rejection
  • Are minimally invasive and require very little downtime, if any — most patients are able to return to their daily activities immediately following the procedure

Unlike traditional treatment options like medication or oxygen therapy, which only work to minimize symptoms of lung disease, stem cell therapy has been shown to potentially relieve lung inflammation and slow the progression of the condition. And because our therapy uses stem cells taken directly from the patient, there is minimal risk of side effects.

If you would like to learn more about the stem cell therapy our treatment centers offer for bronchiectasis patients, call the Lung Institute today at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.